Shares of Tilray Brands Inc. TLRY sank 0.55% to $1.80 Wednesday, on what proved to be an all-around rough trading session for ...

Shares of Tilray Brands Inc. TLRY inched 0.56% higher to $1.81 Tuesday, on what proved to be an all-around mixed trading ...

TLRY acquires the Atwater Brewery, the last in the series of recent acquisitions from Molson Coors. The buyout is likely to ...

Tilray Brands agreed to acquire from DDH a promissory note for $23.8 million payable by 1974568 Ontario Limited.

EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical PrescriptionNEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of ("Tilray Brands") (NASDAQ: TLRY and TSX ...

Tilray Brand's Tilray Medical announced the launch of Redecan EU-GMP certified medical cannabis products in Australia. Tilray ...

Tilray's FY24 growth was driven by M&A, with organic growth lagging and adjusted gross margins declining. See why I remain ...

Cannabis stock Tilray ($TSE:TLRY) is making moves worldwide, and one of its latest comes from its subsidiary, Tilray Medical.

We are initiating coverage on Tilray Brands with a Sell rating, highlighting weak fundamentals and struggles in the cannabis sector. Read more on TLRY stock here.

The Tilray Brands stock price has dropped to a key make-or-break level as the management shifts its approach to focus on ...

Tilray Brands (TSX:TLRY) subsidiary, Tilray Medical, has launched Redecan-branded medical cannabis in Australia ・Products ...